Free Trial

MyMD Pharmaceuticals (MYMD) Short Interest Ratio & Short Volume

MyMD Pharmaceuticals logo
$1.33
-0.09 (-6.34%)
(As of 11/1/2024 ET)

MyMD Pharmaceuticals Short Interest Data

MyMD Pharmaceuticals (MYMD) has a short interest of 263,600 shares, representing 11.82% of the float (the number of shares available for trading by the public). This marks a -6.92% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 134,123 shares to cover all short positions.

Current Short Interest
263,600 shares
Previous Short Interest
283,200 shares
Change Vs. Previous Month
-6.92%
Dollar Volume Sold Short
$485,024.00
Short Interest Ratio
1.1 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
2,370,000 shares
Float Size
2,230,000 shares
Short Percent of Float
11.82%
Today's Trading Volume
31,860 shares
Average Trading Volume
134,123 shares
Today's Volume Vs. Average
24%
Short Selling MyMD Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MYMD Short Interest Over Time

MYMD Days to Cover Over Time

MYMD Percentage of Float Shorted Over Time

MyMD Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2024263,600 shares $485,024.00 -6.9%11.8%1.1 $1.84
6/15/2024283,200 shares $620,208.00 -12.0%12.9%1.2 $2.19
5/31/2024321,800 shares $598,548.00 +96.9%15.2%1.3 $1.86
5/15/2024163,400 shares $343,140.00 -23.8%7.7%0.8 $2.10
4/30/2024214,300 shares $660,044.00 -45.5%10.8%1 $3.08
4/15/2024393,000 shares $892,110.00 +260.2%20.6%1.8 $2.27
3/31/2024109,100 shares $260,749.00 +16.8%5.7%0.5 $2.39
3/15/202493,400 shares $268,992.00 +0.8%5.1%1.7 $2.88
2/29/202492,700 shares $317,961.00 -5.4%5.2%1.6 $3.43
2/15/202498,000 shares $320,460.00 -95.9%5.5%1.7 $3.27
1/31/20242,400,000 shares $360,000.00 -32.4%5.5%1.6 $0.15
1/15/20243,550,000 shares $699,350.00 +3.2%8.2%2.5 $0.20
12/31/20233,440,000 shares $889,928.00 +8.2%7.9%2.8 $0.26
12/15/20233,180,000 shares $731,400.00 -19.5%7.3%3.7 $0.23
11/30/20233,950,000 shares $1.11 million +17.9%9.3%5.4 $0.28
11/15/20233,350,000 shares $1.17 million +2.1%7.9%5.1 $0.35
10/31/20233,280,000 shares $1.39 million -9.6%8.7%5.4 $0.43
10/15/20233,630,000 shares $1.53 million +4.0%9.7%4.5 $0.42
9/30/20233,490,000 shares $2.07 million +19.1%9.3%4.1 $0.59
9/15/20232,930,000 shares $1.80 million -0.7%7.8%3.8 $0.61
8/31/20232,950,000 shares $2.81 million +7.7%8.0%4.1 $0.95
8/15/20232,740,000 shares $3.49 million -32.0%7.4%3.8 $1.28
7/31/20234,030,000 shares $5.84 million +13.8%12.0%5.6 $1.45
7/15/20233,540,000 shares $2.83 million -1.7%10.6%6.7 $0.80
6/30/20233,600,000 shares $5.40 million -2.7%10.7%7.4 $1.50
6/15/20233,700,000 shares $6.07 million +3.9%11.3%7.5 $1.64
5/31/20233,560,000 shares $6.19 million +11.3%10.9%6.5 $1.74
5/15/20233,200,000 shares $6.11 million -0.6%9.8%6.1 $1.91
4/30/20233,220,000 shares $5.83 million +6.3%9.9%6.4 $1.81
4/15/20233,030,000 shares $4.67 million +2.0%9.3%6 $1.54
3/31/20232,970,000 shares $5.11 million +44.2%9.1%6.4 $1.72
3/15/20232,060,000 shares $3.63 million +48.2%6.4%5.3 $1.76
2/28/20231,390,000 shares $2.65 million +47.8%4.3%4.6 $1.91
2/15/2023940,500 shares $2.17 million +18.7%2.9%3.7 $2.31
1/31/2023792,200 shares $2.14 million +9.8%2.4%3.4 $2.70
1/15/2023721,600 shares $1.10 million -1.1%2.2%4.4 $1.52
12/30/2022729,900 shares $839,385.00 -14.8%2.3%4.6 $1.15
12/15/2022856,600 shares $1.16 million -5.1%2.6%5.1 $1.35
11/30/2022902,400 shares $1.93 million +25.8%2.8%5.2 $2.14
11/15/2022717,200 shares $1.43 million +3.4%2.2%4.2 $1.99
We recommended Nvidia in 2016, now we’re recommending this… (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
10/31/2022693,800 shares $1.92 million +1.5%2.1%3.2 $2.77
10/15/2022683,400 shares $1.58 million +1.6%2.1%2.8 $2.31
9/30/2022672,900 shares $1.76 million +5.4%2.1%2.4 $2.61
9/15/2022638,700 shares $2.22 million -6.4%2.0%2.1 $3.48
8/31/2022682,600 shares $2.55 million -2.4%2.0%2.5 $3.74
8/15/2022699,200 shares $3.02 million +24.8%2.0%2.7 $4.32
7/31/2022560,200 shares $2.25 million -25.5%1.7%2.7 $4.02
7/15/2022751,400 shares $3.08 million +102.2%2.3%4.7 $4.10
6/30/2022371,700 shares $806,589.00 -5.4%1.1%2.7 $2.17
6/15/2022392,700 shares $867,867.00 -0.7%1.2%5.7 $2.21
5/31/2022395,500 shares $1.19 million +2.5%1.2%5.7 $3.01
5/15/2022385,800 shares $887,340.00 -14.4%1.2%5.2 $2.30
4/30/2022450,900 shares $1.69 million +0.6%1.4%5.4 $3.74
4/15/2022448,200 shares $1.74 million +2.1%1.4%5 $3.89
3/31/2022439,000 shares $2.05 million -9.0%1.3%4.9 $4.66
3/15/2022482,500 shares $1.61 million -9.5%1.5%4.7 $3.34
2/28/2022533,000 shares $2.13 million +13.5%1.6%5.2 $3.99
2/15/2022469,700 shares $2.38 million -1.4%1.4%3.9 $5.06
1/31/2022476,400 shares $2.09 million -11.1%1.5%3.5 $4.38
1/15/2022536,000 shares $2.60 million -12.2%1.6%3.7 $4.86
12/31/2021610,600 shares $3.70 million -3.3%1.9%3.6 $6.06
12/15/2021631,600 shares $4.13 million -7.0%1.9%3.6 $6.54
11/30/2021678,900 shares $5.20 million -26.7%2.1%3.2 $7.66
11/15/2021925,700 shares $8.35 million +0.8%2.5%4.4 $9.02
10/29/2021918,500 shares $8.80 million +14.9%2.5%4.2 $9.58
10/15/2021799,500 shares $6.31 million -1.4%2.2%3 $7.89
9/30/2021810,600 shares $5.84 million +21.0%2.2%3.4 $7.20
9/15/2021669,700 shares $4.55 million +0.7%1.8%2.8 $6.79
8/31/2021665,300 shares $4.32 million -13.2%1.8%2.5 $6.50
8/13/2021766,400 shares $4.29 million No Change2.1%3.2 $5.60

MYMD Short Interest - Frequently Asked Questions

What is MyMD Pharmaceuticals' current short interest?

Short interest is the volume of MyMD Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 263,600 shares of MYMD short. 11.82% of MyMD Pharmaceuticals' shares are currently sold short. Learn More on MyMD Pharmaceuticals' current short interest.

What is a good short interest ratio for MyMD Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MYMD shares currently have a short interest ratio of 1.0. Learn More on MyMD Pharmaceuticals's short interest ratio.

What is a good short interest percentage for MyMD Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.82% of MyMD Pharmaceuticals' floating shares are currently sold short.

Is MyMD Pharmaceuticals' short interest increasing or decreasing?

MyMD Pharmaceuticals saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 263,600 shares, a drop of 6.9% from the previous total of 283,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is MyMD Pharmaceuticals' float size?

MyMD Pharmaceuticals currently has issued a total of 2,370,000 shares. Some of MyMD Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MyMD Pharmaceuticals currently has a public float of 2,230,000 shares.

How does MyMD Pharmaceuticals' short interest compare to its competitors?

11.82% of MyMD Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to MyMD Pharmaceuticals: Aspira Women's Health Inc. (4.03%), IN8bio, Inc. (0.46%), PharmaCyte Biotech, Inc. (0.30%), Avalo Therapeutics, Inc. (0.52%), Trinity Biotech plc (1.12%), Cara Therapeutics, Inc. (1.33%), Biora Therapeutics, Inc. (4.13%), Mannatech, Incorporated (0.21%), Sensei Biotherapeutics, Inc. (1.35%), ImmunoPrecise Antibodies Ltd. (0.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short MyMD Pharmaceuticals stock?

Short selling MYMD is an investing strategy that aims to generate trading profit from MyMD Pharmaceuticals as its price is falling. MYMD shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against MyMD Pharmaceuticals?

A short squeeze for MyMD Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MYMD, which in turn drives the price of the stock up even further.

How often is MyMD Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYMD, twice per month. The most recent reporting period available is June, 30 2024.




This page (NASDAQ:MYMD) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners